Evidence map›Paper›PMID 30769772›Full record

ArticleInternational journal of molecular sciences2019

MicroRNA-766-3p Contributes to Anti-Inflammatory Responses through the Indirect Inhibition of NF-κB Signaling.

Kunihiro Hayakawa, Mikiko Kawasaki, Takuya Hirai, Yuko Yoshida, Hiroshi Tsushima, Maki Fujishiro, Keigo Ikeda, Shinji Morimoto, Kenji Takamori, Iwao Sekigawa

Open access · goldAbstract read
In one paragraph

Article in International journal of molecular sciences, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 34 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
34citing papers in PubMed, 1 pooled it
1.8field-weighted citation impact, top 17% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

34 citing papers in PubMed, 1 synthesis or guideline pooled it, 58 citations in OpenAlex.

  1. Pooled it
  2. Trial
  3. Article
  4. Article
  5. Review
  6. Non-coding RNA · 2025
    Review
  7. Article
  8. Review
  9. Review
  10. Review
  11. Review
  12. Article
  13. Article
  14. Review
  15. Review
  16. Review
  17. Article
  18. circFLNA promotes intestinal injury during abdominal sepsis through Fas-mediated apoptosis pathway by sponging miR-766-3p.Inflammation research : official journal of the European Histamine Research Society ... [et al.] · 2023
    Article
  19. Review
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors at 2 institutions in 1 country.

Kunihiro HayakawaInstitute for Environment and Gender-Specific Medicine, Juntendo University Graduate School of Medicine, Chiba 279-0021, Japan. khayaka@juntendo.ac.jp.ORCID 0000-0002-8053-746X
Mikiko KawasakiInstitute for Environment and Gender-Specific Medicine, Juntendo University Graduate School of Medicine, Chiba 279-0021, Japan. mikidx@nifty.com.
Takuya HiraiInstitute for Environment and Gender-Specific Medicine, Juntendo University Graduate School of Medicine, Chiba 279-0021, Japan. thirai@juntendo.ac.jp.
Yuko YoshidaInstitute for Environment and Gender-Specific Medicine, Juntendo University Graduate School of Medicine, Chiba 279-0021, Japan. yyoshida@musashino-u.ac.jp.
Hiroshi TsushimaInstitute for Environment and Gender-Specific Medicine, Juntendo University Graduate School of Medicine, Chiba 279-0021, Japan. htsushi@juntendo.ac.jp.
Maki FujishiroInstitute for Environment and Gender-Specific Medicine, Juntendo University Graduate School of Medicine, Chiba 279-0021, Japan. mfujishi@juntendo.ac.jp.
Keigo IkedaDepartment of Internal Medicine and Rheumatology, Juntendo University Urayasu Hospital, Chiba 279-0021, Japan. keigo@juntendo.ac.jp.ORCID 0000-0002-8032-7147
Shinji MorimotoDepartment of Internal Medicine and Rheumatology, Juntendo University Urayasu Hospital, Chiba 279-0021, Japan. morimoto@juntendo.ac.jp.
Kenji TakamoriInstitute for Environment and Gender-Specific Medicine, Juntendo University Graduate School of Medicine, Chiba 279-0021, Japan. ktakamor@juntendo.ac.jp.
Iwao SekigawaInstitute for Environment and Gender-Specific Medicine, Juntendo University Graduate School of Medicine, Chiba 279-0021, Japan. isekigawa@mva.biglobe.ne.jp.
Juntendo University · JPJuntendo University Urayasu Hospital · JP

Funding

Japan Society for the Promotion of Science 18K08415Japan Society for the Promotion of Science JP26860265Ministry of Education, Culture, Sports, Science and Technology S1311011
6 · The paper itself

Abstract

MicroRNA (miRNA) is small RNA of 20 to 22 nucleotides in length and is stably present in plasma. Regulating the expression of miRNA taken into cells has been suggested as a general therapeutic approach. We identified the novel anti-inflammatory miRNA hsa-miR-766-3p and investigated its biological function in human rheumatoid arthritis (RA) fibroblast-like synoviocyte MH7A cells. To verify the function of the miRNA present in the plasma of RA patients, we performed a comprehensive analysis of the miRNA expression during abatacept treatment and identified eight miRNAs with significantly altered expression levels. Among these eight miRNAs, miR-766-3p was found to have a clear function. The expression of inflammatory genes in response to inflammatory stimuli was suppressed in MH7A transduced with miR-766-3p. We showed that miR-766-3p indirectly reduced the activation of NF-κB and clarified that this mechanism was partially involved in the reduction of the mineralocorticoid receptor expression. In addition, the inflammatory responses were suppressed in other types of cells. These results indicate the novel function of miR-766-3p, findings that may aid in the development of therapies to suppress inflammation, not only in RA but also in other diseases.

Indexed as

AbataceptAnti-Inflammatory AgentsArthritis, RheumatoidGene Expression RegulationHumansInflammationMicroRNAsNF-kappa BReceptors, MineralocorticoidSignal TransductionSynoviocytesAbataceptAnti-Inflammatory AgentsMicroRNAsMIRN766 microRNA, humanNF-kappa BReceptors, Mineralocorticoidabataceptinflammationinterleukin(IL)-1βmicroRNA (miRNA)mineralocorticoid receptornuclear factor-κB (NF-κB)rheumatoid arthritis (RA)tumor necrosis factor-α (TNF-α)

Identifiers

PMID30769772
PMCPMC6413049
OpenAlexW2911887615

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.